ImmuPharma plc (LON:IMM – Get Free Report)’s share price dropped 11.7% during trading on Thursday . The stock traded as low as GBX 3.75 ($0.05) and last traded at GBX 3.80 ($0.05). Approximately 14,936,349 shares were traded during trading, a decline of 25% from the average daily volume of 19,799,125 shares. The stock had previously closed at GBX 4.31 ($0.05).
ImmuPharma Trading Up 2.6 %
The firm has a fifty day moving average of GBX 2.77 and a 200 day moving average of GBX 2.04. The company has a market capitalization of £16.58 million, a P/E ratio of -6.74 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- How to Find Undervalued Stocks
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
